Number of Americans fully vaccinated tops 100 million

DALLAS — Disneyland reopened Friday and cruise lines welcomed the news that they could be sailing again in the U.S. by midsummer, as the number of Americans fully vaccinated against COVID-19 reached another milestone: 100 million.

Analysis: Expected COVID baby boom might be a baby bust

NEW YORK — When most of the U.S. went into lockdown more than a year ago, some speculated that confining couples to their homes — with little to entertain them beyond Netflix — would lead to a lot of baby-making. But the statistics suggest the opposite.

Asian Americans wary about school amid virus, violence

BOSTON — A Chinese American mother in the Boston suburbs is sending her sons to in-person classes this month, even after one of them was taunted with a racist “slanted-eyes” gesture at school, just days after the killings of women of Asian descent at massage businesses in Atlanta.

Alaska tribal health groups distribute vaccine far and wide

JUNEAU, Alaska — John Waghiyi remembers rushing his cousin to the clinic in the Bering Sea city of Savoonga in December, worried he was having a possible heart attack while out butchering a bowhead whale. Waghiyi arrived to see elders waiting in the lobby for a COVID-19 vaccine.

Half of US adults have received at least one COVID-19 shot

WASHINGTON — Half of all adults in the U.S. have received at least one COVID-19 vaccine shot, the government announced Sunday, marking another milestone in the nation’s largest-ever vaccination campaign but leaving more work to do to convince skeptical Americans to roll up their sleeves.

US opens more distance in worldwide race against coronavirus

The United States opened more distance between itself and much of the rest of the world Thursday, nearing the 200 millionth vaccine administered in a race to protect the population against COVID-19, even as other countries, rich and poor, struggle with stubbornly high infection rates and deaths.

J&J vaccine to remain in limbo while officials seek evidence

Johnson & Johnson’s COVID-19 vaccine will remain in limbo for a while longer after government health advisers declared Wednesday that they need more evidence to decide if a handful of unusual blood clots were linked to the shot — and if so, how big the risk really is.